Wolf Named an “Intellectual Property Litigator of the Year” by Benchmark Litigation
Intellectual Property practice co-chair Matthew Wolf was named as the East Coast “Intellectual Property Litigator of the Year” by Benchmark Litigation. The Benchmark Litigation Awards recognize “the country’s most distinguished litigators and their firms for their exemplary work over the past twelve months.”
Wolf was honored for his groundbreaking biotechnology patent victory for Sanofi and Regeneron at the Federal Circuit and his defense of the assignor estoppel doctrine at the US Supreme Court for Hologic. In Amgen Inc. v. Sanofi, Arnold & Porter earned an important win for Sanofi and Regeneron earlier this year before the Federal Circuit on the issue of the "enablement" of patent claims covering therapeutic antibodies. In Hologic v. Minerva, Arnold & Porter prevailed before the US Supreme Court on behalf of longtime client Hologic on the issue of "assignor estoppel," an equitable doctrine that prevents those who assign/sell patent rights from later challenging the validity of the rights they sold. Last year, Wolf was named a Law360 MVP for his outstanding intellectual property litigation work.
Wolf has been recognized as a "key individual" for his achievements in patent litigation in Chambers USA. He has been named both a Winning Litigator and Trailblazer by The National Law Journal. He also is top ranked by IAM's Patent Litigation 1000: The World's Leading Patent Litigators, which has noted that he is a "trial supremo"; a "smart guy who knows how to frame the best case," with "tremendous trial skills and a superb ability to think on his feet," and "his cross-examination skills are some of the best."